Why is a curable disease allowed to kill millions?
John Green, the author of several books and a longtime supporter of Partners in Health, discusses his time visiting Sierra Leone’s Lakka Government Hospital, a tuberculosis treatment center. He talks about Henry, a 16-year old boy cured from multi-drug resistant TB as the first Sierra Leonean patient to receive a newly designed treatment regimen that included bedaquiline in 2021. With J&J's patent on bedaquiline ending soon, John Green provides us with a call to action to urge J&J to relinquish its extended patent claims and make the drug more widely accessible and affordable. Read more here.